SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-014494
Filing Date
2022-04-14
Accepted
2022-04-14 17:00:53
Documents
12
Period of Report
2022-04-05
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K imra-8k_20220405.htm   iXBRL 8-K 42942
  Complete submission text file 0001564590-22-014494.txt   177252

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA imra-20220405.xsd EX-101.SCH 5673
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE imra-20220405_lab.xml EX-101.LAB 20178
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE imra-20220405_pre.xml EX-101.PRE 12019
6 EXTRACTED XBRL INSTANCE DOCUMENT imra-8k_20220405_htm.xml XML 3667
Mailing Address 116 HUNTINGTON AVENUE 6TH FLOOR BOSTON MA 02116
Business Address 116 HUNTINGTON AVENUE 6TH FLOOR BOSTON MA 02116 617-206-2020
IMARA Inc. (Filer) CIK: 0001672619 (see all company filings)

IRS No.: 811523849 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39247 | Film No.: 22828052
SIC: 2834 Pharmaceutical Preparations